Status:
COMPLETED
Extracorporeal Shock Wave Therapy (ESWT) for the Treatment of Spasticity in Persons With Spinal Cord Injury
Lead Sponsor:
Swiss Paraplegic Research, Nottwil
Conditions:
Spinal Cord Injury
Spasticity
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Spasticity is the most problematic self-reported secondary medical problem in patients with spinal cord injury. It has the potential to negatively influence quality of life through restricting activit...
Eligibility Criteria
Inclusion
- Traumatic or non traumatic spinal cord injury
- Minimum age: 18 years
- Minimum time since spinal cord injury: two years
- Lesion: C3-Th10
- American Association of Spinal Cord Injury Impairment Score C and D
- Focal spasticity in the adductor muscles and/ or triceps surae
- Ability to walk 14 meters
- Spasticity/clonus/spasms disturbing the activities of daily living or participation
Exclusion
- Changes in spasticity medication during the last 3 months
- Treatment with botulinum toxin during the last 6 months
- Anticoagulant medication
- Thrombosis
- Malignant tumors
- Pregnancy
- Inflammations or skin lesions in the treated area
- Acute urinary tract infection
- Intended change in spasticity medication within 5 days after intervention
Key Trial Info
Start Date :
July 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT02203994
Start Date
July 1 2014
End Date
December 1 2016
Last Update
January 26 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Swiss Paraplegic Centre
Nottwil, Canton of Lucerne, Switzerland, 6207